Li N, Deng WY, Ma YH, Chen XB, Han LL, Lv HF, Chen BB, Luo SX. Correlation of expression of Nanog, Oct-4 and SOX-2 with tumor metastasis in colonic cancer.
Shijie Huaren Xiaohua Zazhi 2011;
19:2644-2648. [DOI:
10.11569/wcjd.v19.i25.2644]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the expression of Nanog, Oct-4 and SOX-2 in colonic carcinoma and to analyze their relationship with tumor metastasis.
METHODS: Immunohistochemistry was used to evaluate the expression of Nanog, Oct-4 and SOX-2 in 80 colonic cancer surgical specimens. The correlation of Nanog, Oct-4 and SOX-2 expression with tumor histological differentiation, T stage, N stage and metastasis was analyzed.
RESULTS: Thirty-five patients had metastasis. The positive rates of SOX-2, Oct-4 and Nanog expression were significantly higher in the metastasis group than in the non-metastasis group (48.57% vs 17.78%, 51.43% vs 13.33%, 60% vs 26.67%, all P < 0.05). Nanog expression was significantly correlated with differentiation (P = 0.001), but expression of Nanog, Oct-4 and SOX-2 was not associated with T stage or N stage. Metastatic rate was higher in patients with positive expression of the three markers than in those with negative expression. Survival analysis showed that the time to develop metastasis was significant different among patients with differential expression of the three markers (P = 0.0001).
CONCLUSION: The expression of Nanog, Oct-4 and SOX-2 in tumor tissue can predict the postoperative metastasis of colonic cancer. Nanog, Oct-4 and SOX-2 are promising predictors for metastasis of colonic cancer.
Collapse